Tiotropium placebo

DRUG2 trials

Sponsors

Boehringer Ingelheim, Theravance Biopharma

Conditions

Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic Obstructive

Phase 2

Tiotropium Respimat Pharmacokinetic Study in COPD

CompletedNCT01222533

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2010-10-31Updated: 2014-05-16

Phase 4

Phase 4 COPD and Suboptimal Inspiratory Flow Rate

CompletedNCT05165485

Theravance BiopharmaChronic Obstructive Pulmonary Disease

Start: 2022-01-07End: 2023-11-20Updated: 2024-12-20

Related Papers

Tiotropium Respimat: Comparison of bronchodilator efficacy of 5 and 2.5 µg doses

Pneumologie2015-02-04

The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale.

2013-04-0240 citations